edrophonium has been researched along with Atrial Flutter in 4 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
Atrial Flutter: Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atrial flutter has a fully excitable gap, and procainamide does not convert the gap from full to partial excitability." | 1.29 | Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stambler, BS | 2 |
| Wood, MA | 1 |
| Ellenbogen, KA | 2 |
| Cummings, P | 1 |
| Reddy, RC | 1 |
| Gould, L | 1 |
| Gomprecht, RF | 1 |
4 other studies available for edrophonium and Atrial Flutter
| Article | Year |
|---|---|
Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
Topics: Action Potentials; Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artifici | 1996 |
Elucidating the mechanisms of atrial flutter cycle length variability using power spectral analysis techniques.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Flutter; Edrophonium; Heart; Heart Transplantation; | 1996 |
Supraventricular tachycardias in the emergency room.
Topics: Atrial Fibrillation; Atrial Flutter; Digoxin; Edrophonium; Electric Countershock; Emergencies; Human | 1985 |
Use of edrophonium (tensilon) in the evaluation of cardiac arrhythmias.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Diagnosis, Differentia | 1971 |